These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 26983987)
1. The impact of hypoxia and its modification of the outcome of radiotherapy. Horsman MR; Overgaard J J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i90-i98. PubMed ID: 26983987 [TBL] [Abstract][Full Text] [Related]
3. Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers. Overgaard J; Horsman MR Semin Radiat Oncol; 1996 Jan; 6(1):10-21. PubMed ID: 10717158 [TBL] [Abstract][Full Text] [Related]
4. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology. Weinmann M; Welz S; Bamberg M Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083 [TBL] [Abstract][Full Text] [Related]
5. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Wouters BG; Brown JM Radiat Res; 1997 May; 147(5):541-50. PubMed ID: 9146699 [TBL] [Abstract][Full Text] [Related]
7. Hypoxic tumor cell radiosensitization through nitric oxide. De Ridder M; Verellen D; Verovski V; Storme G Nitric Oxide; 2008 Sep; 19(2):164-9. PubMed ID: 18474256 [TBL] [Abstract][Full Text] [Related]
8. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies. Bache M; Kappler M; Said HM; Staab A; Vordermark D Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988 [TBL] [Abstract][Full Text] [Related]
9. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Wouters A; Pauwels B; Lardon F; Vermorken JB Oncologist; 2007 Jun; 12(6):690-712. PubMed ID: 17602059 [TBL] [Abstract][Full Text] [Related]
10. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway. De Ridder M; Van Esch G; Engels B; Verovski V; Storme G Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Overgaard J Oncol Res; 1994; 6(10-11):509-18. PubMed ID: 7620219 [TBL] [Abstract][Full Text] [Related]
12. A voxel-based multiscale model to simulate the radiation response of hypoxic tumors. Espinoza I; Peschke P; Karger CP Med Phys; 2015 Jan; 42(1):90-102. PubMed ID: 25563250 [TBL] [Abstract][Full Text] [Related]
13. Tumor hypoxia: its impact on cancer therapy. Moulder JE; Rockwell S Cancer Metastasis Rev; 1987; 5(4):313-41. PubMed ID: 3552280 [TBL] [Abstract][Full Text] [Related]
14. Chemical modifiers of cancer treatment. Coleman CN; Bump EA; Kramer RA J Clin Oncol; 1988 Apr; 6(4):709-33. PubMed ID: 3282035 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia in head and neck cancer: how much, how important? Janssen HL; Haustermans KM; Balm AJ; Begg AC Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198 [TBL] [Abstract][Full Text] [Related]
16. Chemical radiosensitizers for use in radiotherapy. Wardman P Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Moeller BJ; Richardson RA; Dewhirst MW Cancer Metastasis Rev; 2007 Jun; 26(2):241-8. PubMed ID: 17440683 [TBL] [Abstract][Full Text] [Related]
19. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Graham K; Unger E Int J Nanomedicine; 2018; 13():6049-6058. PubMed ID: 30323592 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing. Kabakov AE; Yakimova AO Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33806538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]